Tumor-specific CD4 T cells instruct monocyte fate in pancreatic ductal adenocarcinoma is a research paper published in Cell Reports (2023). On theSindex it has a DataRank of 0. It has been cited 53 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: F31CA275289
National Cancer Institute
Grant: P01CA254849
National Cancer Institute
Grant: R01CA249393
National Cancer Institute
Grant: R01CA255039
American Cancer Society
Grant: 124166-IRG-58-001-55-IRG65
U.S. Department of Defense
Grant: 19-35-STRO
U.S. Department of Defense
Grant: PA200286
Ministry of Education and Science of the Russian Federation
Grant: 075-15-2022-301
Ministry of Education and Science of the Russian Federation
Grant: R01AI165553
Ministry of Education and Science of the Russian Federation
Grant: CDA 855022
National Institutes of Health
Grant: T32 AG029796
American Heart Association
Grant: 903380
NIAID NIH HHS
Grant: T32 AI007313
National Institutes of Health
Grant: 5R01AI165553-02
Sex and stress hormones control adrenal gland macrophage development and function"
National Institutes of Health
Grant: 5F31CA275289-02
Elucidating the Role of Tregs in Cancer Metastasis and T Cell Dysfunction
National Institutes of Health
Grant: 5R01CA249393-03
Mechanisms of immunotherapy response and resistance in pancreatic ductal adenocarcinoma
National Institutes of Health
Grant: 2T32AG029796-11
Functional Proteomics of Aging
National Institutes of Health
Grant: 5P01CA254849-02
Integrated Immune Engineering for Poor Prognosis Cancers
National Institutes of Health
Grant: 1R01CA255039-01A1
Enhancing engineered T cell therapeutic efficacy for the treatment of pancreatic ductal adenocarcinoma
Pancreatic Cancer Action Network
FWCI
6.17
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Immunoglobulin superfamily 6 is a molecule involved in the anti-tumor activity of macrophages in lung adenocarcinoma
Additional file 1 of Immunoglobulin superfamily 6 is a molecule involved in the anti-tumor activity of macrophages in lung adenocarcinoma
Additional file 2 of Immunoglobulin superfamily 6 is a molecule involved in the anti-tumor activity of macrophages in lung adenocarcinoma
Additional file 2 of Immunoglobulin superfamily 6 is a molecule involved in the anti-tumor activity of macrophages in lung adenocarcinoma
Additional file 3 of Immunoglobulin superfamily 6 is a molecule involved in the anti-tumor activity of macrophages in lung adenocarcinoma
Additional file 3 of Immunoglobulin superfamily 6 is a molecule involved in the anti-tumor activity of macrophages in lung adenocarcinoma
Additional file 4 of Immunoglobulin superfamily 6 is a molecule involved in the anti-tumor activity of macrophages in lung adenocarcinoma
Additional file 4 of Immunoglobulin superfamily 6 is a molecule involved in the anti-tumor activity of macrophages in lung adenocarcinoma
Additional file 5 of Immunoglobulin superfamily 6 is a molecule involved in the anti-tumor activity of macrophages in lung adenocarcinoma
Additional file 5 of Immunoglobulin superfamily 6 is a molecule involved in the anti-tumor activity of macrophages in lung adenocarcinoma
Additional file 6 of Immunoglobulin superfamily 6 is a molecule involved in the anti-tumor activity of macrophages in lung adenocarcinoma
Additional file 6 of Immunoglobulin superfamily 6 is a molecule involved in the anti-tumor activity of macrophages in lung adenocarcinoma